Compare HUT & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HUT | MEDP |
|---|---|---|
| Founded | 2011 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 15.4B |
| IPO Year | 2023 | 2016 |
| Metric | HUT | MEDP |
|---|---|---|
| Price | $79.56 | $620.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 12 |
| Target Price | $65.20 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 5.0M | 256.2K |
| Earning Date | 05-06-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.98 |
| EPS | N/A | ★ 8.53 |
| Revenue | ★ $235,118,000.00 | N/A |
| Revenue This Year | $161.69 | $13.19 |
| Revenue Next Year | N/A | $7.75 |
| P/E Ratio | ★ N/A | $72.77 |
| Revenue Growth | ★ 44.79 | N/A |
| 52 Week Low | $23.03 | $373.00 |
| 52 Week High | $140.80 | $677.90 |
| Indicator | HUT | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 39.44 | 64.57 |
| Support Level | $44.85 | $567.90 |
| Resistance Level | $83.18 | $627.59 |
| Average True Range (ATR) | 7.94 | 16.59 |
| MACD | -0.71 | 0.31 |
| Stochastic Oscillator | 11.24 | 78.70 |
Hut 8 Corp is an energy infrastructure platform that integrates power, digital infrastructure, and compute at scale to fuel next-generation, energy-intensive use cases. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.